Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ines Vaz-Luis

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Expert Review of Anticancer Therapy|September 7, 2018
Managing side effects in adjuvant endocrine therapy for breast cancerRosaria Condorelli, Ines Vaz-Luis
The Lancet. Oncology|March 16, 2020
Is HER2-positive metastatic breast cancer still an incurable disease?Matteo Lambertini, Ines Vaz-Luis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Reply to H.L. McArthur et alInes Vaz-Luis, Nancy U Lin
JAMA Oncology|September 16, 2016
Optimizing Adjuvant Chemotherapy and Surgery for Early- and Late-Stage Breast CancerInes Vaz-Luis, Harold J Burstein
Nature Reviews. Clinical Oncology|January 24, 2018
Exogenous reproductive hormone use in breast cancer survivors and previvorsInes Vaz-Luis, Ann H Partridge
BMJ (Clinical Research Ed.)|October 8, 2015
With better adjuvant therapy, does breast cancer stage still matter?Ines Vaz-Luis, Harold J Burstein
Critical Reviews in Oncology/Hematology|December 14, 2020
Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic reviewPietro Lapidari, Ines Vaz-Luis, Antonio Di Meglio
Journal of the National Cancer Institute|November 12, 2023
Response to SorscherFélix Balazard, Aurélie Bertaut, Ines Vaz-Luis, et al.
Current Opinion in Oncology|August 30, 2021
Lifestyle and quality of life in patients with early-stage breast cancer receiving adjuvant endocrine therapyAntonio Di Meglio, Davide Soldato, Daniele Presti, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 14, 2021
Challenges in Adjuvant Therapy for Premenopausal Women Diagnosed With Luminal Breast CancersInes Vaz-Luis, Prudence A Francis, Antonio Di Meglio, et al.
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Expert Review of Anticancer Therapy|September 7, 2018
Managing side effects in adjuvant endocrine therapy for breast cancerRosaria Condorelli, Ines Vaz-Luis
The Lancet. Oncology|March 16, 2020
Is HER2-positive metastatic breast cancer still an incurable disease?Matteo Lambertini, Ines Vaz-Luis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Reply to H.L. McArthur et alInes Vaz-Luis, Nancy U Lin
JAMA Oncology|September 16, 2016
Optimizing Adjuvant Chemotherapy and Surgery for Early- and Late-Stage Breast CancerInes Vaz-Luis, Harold J Burstein
Nature Reviews. Clinical Oncology|January 24, 2018
Exogenous reproductive hormone use in breast cancer survivors and previvorsInes Vaz-Luis, Ann H Partridge
BMJ (Clinical Research Ed.)|October 8, 2015
With better adjuvant therapy, does breast cancer stage still matter?Ines Vaz-Luis, Harold J Burstein
Critical Reviews in Oncology/Hematology|December 14, 2020
Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic reviewPietro Lapidari, Ines Vaz-Luis, Antonio Di Meglio
Journal of the National Cancer Institute|November 12, 2023
Response to SorscherFélix Balazard, Aurélie Bertaut, Ines Vaz-Luis, et al.
Current Opinion in Oncology|August 30, 2021
Lifestyle and quality of life in patients with early-stage breast cancer receiving adjuvant endocrine therapyAntonio Di Meglio, Davide Soldato, Daniele Presti, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 14, 2021
Challenges in Adjuvant Therapy for Premenopausal Women Diagnosed With Luminal Breast CancersInes Vaz-Luis, Prudence A Francis, Antonio Di Meglio, et al.
Pageof 13